FTAC Emerald Acquisition Corp. (NASDAQ: EMLD) announced that on March 16, it signed a non-binding letter of intent (LOI) to combine with an unnamed target.
With a completion deadline of June 20, FTAC Emerald was set to expire, but now that it has announced a signed LOI in hand, the company will receive an automatic extension of three months, giving it a new deadline of September 20.
The SPAC announced the pricing of its $220 million IPO in December 2021. It did not disclose further details on today’s potential merger or the target itself, but initially intended on combining with a target that achieves best-in-class standards in environmental, social, and governance (ESG) practices. FTAC Emerald is led by Chairman Betsy Cohen, President and CEO Bracebridge H. Young, Jr., Vice Chairman Mark Tercek, and CFO Doug Listman.
Because there is no guarantee that this LOI will be completed, FTAC Emerald will remain in SPACInsider’s “Searching” column until a definitive agreement is signed.
Vendome Acquisition Corporation I (NASDAQ:VNMEU) announced the pricing of its $200 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “VNMEU”, Wednesday, July 2, 2025. The new SPAC plans to focus its search on target business in the consumer sector operating in North America, Southeast Asia, and Europe....
Origin Investment Corp. I (NASDAQ:ORIQU) announced the pricing of its $60 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “ORIQU”, Wednesday, July 2, 2025. The new SPAC aims to mount a broad search for a target with a strong management and both revenue and earnings growth potential....
1RT Acquisition Corp. (NASDAQ:ONCHU) announced the pricing of its $150 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “ONCHU”, Wednesday, July 2, 2025. The new SPAC plans to target company in the digital asset ecosystem involved in the creation, storage, exchange or management of such assets, whether...
D. Boral ARC Acquisition II Corp. (NASDAQ:ARBCU) has filed for a $250 million SPAC to give underwriter D. Boral a second in-house SPAC to pursue deals with. The new SPAC offers investors a 1/2 warrant and an initial 18-month time frame to complete a deal. D. Boral II’s sponsor may automatically extend this once by...
Ribbon (NASDAQ:RIBB) has entered into a definitive agreement to combine with Japanese biotech firm DRC Medicine at a pro forma equity value of $422 million. Tokyo-based DRC Medicine manufactures reusable anti-bacterial and anti-allergen wearables and aims to go deeper into the medical device and pharmaceutical space. Transaction Overview Ribbon is expected to provide $50.4 million...